NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

OK, here is the quote:

So in reality, I think, you know, what we’re really comparing now is actually early DC vaccinations versus later DC vaccinations

The "early vs late" clearly refers to the OS secondary.

The PI for the trial stated clearly that what they are really looking at now is the secondary endpoint.

Furthermore, she places the "not reached" statement within two paragraphs or so of discussion of OS and crossover. Kind of odd when PFS events would not be effected by this. I guess she was just sloppy, but that would be an odd character trait for a brain surgeon.

And please drop the strawman points. I never claimed she said anything about PFS results, or that OS was the only thing being looked at.